Semi-continuous multi-step synthesis of lamivudine

Area of Science:

• Chemical synthesis
• Organic chemistry
• Pharmaceutical manufacturing

Background:

• Lamivudine is a crucial antiretroviral drug for HIV/AIDS and hepatitis B treatment.
• Traditional batch synthesis methods can be inefficient and difficult to scale.
• Continuous flow chemistry offers potential advantages in drug synthesis.

Purpose of the Study:

• To develop the first continuous flow synthesis of lamivudine.
• To optimize the synthesis of a key intermediate and the glycosidation reaction.
• To improve the overall yield and efficiency of lamivudine production.

Main Methods:

• An integrated two-step continuous flow process was employed for intermediate synthesis.
• L-menthyl glyoxalate hydrate was used as the starting material in a single solvent.
• A novel catalyst, pyridinium triflate, was utilized for the glycosidation step.

Main Results:

• The key intermediate (5-acetoxy oxathiolane) was synthesized with 95% overall conversion.
• The glycosidation reaction achieved an improved conversion of 95%.
• The overall isolated yield of lamivudine was 40%, an improvement over batch processes.

Conclusions:

• Continuous flow synthesis is a viable and improved method for producing lamivudine.
• The developed process offers higher efficiency and yield compared to traditional batch methods.
• This advancement has implications for the scalable manufacturing of antiretroviral drugs.